Skip to main content
. Author manuscript; available in PMC: 2014 Nov 15.
Published in final edited form as: Clin Cancer Res. 2013 Oct 4;19(22):10.1158/1078-0432.CCR-13-1848. doi: 10.1158/1078-0432.CCR-13-1848

Figure 3. Duration of overall response after BR.

Figure 3

Patients achieving CR as best response (solid line) remain in major response (6 in CR, 1 relapsing to PR), compared to all of 5 with best response of PR (dashed line) relapsing at 11–29 (median 20) months (p<0.001).